Cogent Biosciences (COGT) EBITDA Margin Growth (1y) (2018 - 2020)
Cogent Biosciences (COGT) EBITDA Margin Growth (1y) (2018 - 2020) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBITDA Margin Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
788,338.31 Bn |
788,338.28 Bn |
- |
- |
| 2 |
Belite Bio |
56,560.00 Bn |
56,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,329.30 Bn |
17,329.30 Bn |
- |
- |
| 4 |
Legend Biotech |
3,341.00 Bn |
3,340.71 Bn |
242.10 Mn |
3,609.00 |
| 5 |
Akari Therapeutics |
1,727.91 Bn |
1,727.91 Bn |
- |
- |
| 6 |
Evaxion A |
1,536.68 Bn |
1,536.67 Bn |
- |
- |
| 7 |
Psyence Biomedical |
238.34 Bn |
238.33 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.42 Bn |
106.17 Bn |
2.59 Bn |
1,536.00 |
| 9 |
Abivax |
95.45 Bn |
95.45 Bn |
- |
- |
| 10 |
Cogent Biosciences |
5.19 Bn |
4.32 Bn |
- |
- |
| Date | Value |
|---|
| Sep 30, 2020 |
-1.49 Mn |
| Jun 30, 2020 |
-106,514.00 |
| Mar 31, 2020 |
29,593.00 |
| Dec 31, 2019 |
24,089.00 |
| Sep 30, 2019 |
-67,068.00 |
| Jun 30, 2019 |
20,690.00 |
| Mar 31, 2019 |
-7,963.00 |
| Dec 31, 2018 |
8,888.00 |
| Sep 30, 2018 |
-19,875.00 |
| Jun 30, 2018 |
-25,961.00 |
| Mar 31, 2018 |
2,275.00 |
